Literature DB >> 35059038

Molecular interactions of IRF4 in B cell development and malignancies.

Srinivasan Sundararaj1, Marco G Casarotto1.   

Abstract

Interferon regulatory factor 4 (IRF4) is a lymphoid transcription factor and a key regulator in the development of various immune cells, including T and B cells. It is well-known that IRF4 controls numerous decision-making processes relating to B cell development, including differentiation, maturation, and signalling. Consequently, genetic alterations that affect the functional aspects of IRF4 can result in clonal transformation and have been identified in various lymphoid malignancies. Over the last decades, a series of studies have demonstrated the critical cellular and structural basis underpinning IRF4-mediated B cell development and associated malignancies. In this review, we will briefly summarise the recent advances in understanding IRF4-mediated B cell development and related malignancies, with a particular focus on the molecular aspects that govern these processes. © International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag GmbH Germany, part of Springer Nature 2021.

Entities:  

Keywords:  B cell development; B cell malignancies; Interferon regulatory factor 4; Molecular interactions

Year:  2021        PMID: 35059038      PMCID: PMC8724474          DOI: 10.1007/s12551-021-00825-6

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  63 in total

1.  Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences.

Authors:  Y Fujii; T Shimizu; M Kusumoto; Y Kyogoku; T Taniguchi; T Hakoshima
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

Review 2.  Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.

Authors:  Sorim Nam; Jong-Seok Lim
Journal:  Arch Pharm Res       Date:  2016-11-09       Impact factor: 4.946

3.  Detection of MUM1/IRF4-IgH fusion in multiple myeloma.

Authors:  S Yoshida; N Nakazawa; S Iida; Y Hayami; S Sato; A Wakita; S Shimizu; M Taniwaki; R Ueda
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

4.  Crystal structure of PU.1/IRF-4/DNA ternary complex.

Authors:  Carlos R Escalante; Abraham L Brass; Jagan M R Pongubala; Ella Shatova; Leyi Shen; Harinder Singh; Aneel K Aggarwal
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

5.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

6.  Crystal structure of a CAP-DNA complex: the DNA is bent by 90 degrees.

Authors:  S C Schultz; G C Shields; T A Steitz
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

7.  Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism.

Authors:  Simon N Willis; Kim L Good-Jacobson; Joan Curtis; Amanda Light; Julie Tellier; Wei Shi; Gordon K Smyth; David M Tarlinton; Gabrielle T Belz; Lynn M Corcoran; Axel Kallies; Stephen L Nutt
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

8.  Compensatory dendritic cell development mediated by BATF-IRF interactions.

Authors:  Roxane Tussiwand; Wan-Ling Lee; Theresa L Murphy; Mona Mashayekhi; Wumesh KC; Jörn C Albring; Ansuman T Satpathy; Jeffrey A Rotondo; Brian T Edelson; Nicole M Kretzer; Xiaodi Wu; Leslie A Weiss; Elke Glasmacher; Peng Li; Wei Liao; Michael Behnke; Samuel S K Lam; Cora T Aurthur; Warren J Leonard; Harinder Singh; Christina L Stallings; L David Sibley; Robert D Schreiber; Kenneth M Murphy
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

9.  Mutational analysis of primary central nervous system lymphoma.

Authors:  Aurélie Bruno; Blandine Boisselier; Karim Labreche; Yannick Marie; Marc Polivka; Anne Jouvet; Clovis Adam; Dominique Figarella-Branger; Catherine Miquel; Sandrine Eimer; Caroline Houillier; Carole Soussain; Karima Mokhtari; Romain Daveau; Khê Hoang-Xuan
Journal:  Oncotarget       Date:  2014-07-15

10.  Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response.

Authors:  Julie Tellier; Wei Shi; Martina Minnich; Yang Liao; Simon Crawford; Gordon K Smyth; Axel Kallies; Meinrad Busslinger; Stephen L Nutt
Journal:  Nat Immunol       Date:  2016-01-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.